Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes

Author:

Runge Ava S.1,Kennedy Lynn1,Brown Adam S.12,Dove Abigail E.2,Levine Brian J.2,Koontz Sophie P.3,Iyengar Varun S.4,Odeh Sarah A.2,Close Kelly L.12,Hirsch Irl B.5,Wood Richard3

Affiliation:

1. The diaTribe Foundation, San Francisco, CA

2. Close Concerns, San Francisco, CA

3. dQ&A Market Research, Inc., San Francisco, CA

4. Brown University, Providence, RI

5. University of Washington, Seattle, WA

Abstract

IN BRIEF After assessing patient perspectives on the success of current diabetes therapies and the factors that have the greatest impact on daily life, we show that time-in-range is a crucial outcome for people with diabetes and that current therapies are falling short on this metric. We also show that patients feel significant stress and worry, and they believe they are falling short in diet, exercise, and weight maintenance. In addition, they believe diet and exercise and in-range blood glucose are the biggest drivers of improved diabetes management and mindset. Together, these findings support the need for therapies that improve outcomes including and beyond A1C.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. Economic costs of diabetes in the U.S. in 2012;American Diabetes Association;Diabetes Care,2013

2. Centers for Disease Control and Prevention . National diabetes statistics report, 2014. Available from CDC.gov. https://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed 20 December 2016

3. Depression and advanced complications of diabetes: a prospective cohort study;Lin;Diabetes Care,2010

4. Diabetes Control and Complications Trial (DCCT): results of feasibility study;DCCT Research Group.;Diabetes Care,1987

5. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes;King;Br J Clin Pharmacol,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3